RxDoctor Payments Data

Bradley Christiansen, DPM

Podiatrist · Grandville, MINPI 1356846703

Payments from drug & device makers

What this record shows

11 manufacturers reported payments, led by Pinnacle, Inc at 46.8% of the total. Reporting peaked in 2021 at $3,231 and has fallen 79.0% since, to $680 in 2025.

$5,143in general payments, 2019–2025

Across 43 payments — averaging $119.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pinnacle, Inc$2K
  • Stryker$930
  • Osteomed LLC$502
  • Acumed LLC$315
  • Paragon 28, Inc.$292
  • Kerecis Limited$274
  • plus $421 from 5 others

What the payments were for

  • Food & beverage$2,47748%
  • Education$2,66652%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pinnacle, Inc3$2,408
Stryker10$930
Osteomed LLC7$502
Acumed LLC3$315
Paragon 28, Inc.8$292
Kerecis Limited1$274
Johnson & Johnson(2 entities)5$198
Integra Lifesciences Corporation3$186
Medwest Associates1$16
Lightbody Medical Technologies Inc1$15
Orthofix Medical, Inc.1$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,143 in reported general payments places this provider in the 80th percentile of 302 podiatrist providers in Michigan.

See all podiatrist providers in Michigan

Medicare billing

Part B allowed, 2024
$40,192
Medicare patients
174
Services billed
539

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox45$814
Ammonium Lactate24$746
Doxycycline Hyclate38$241
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$144
Meloxicam42$109
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$37

Paid to pharmacies, not to this prescriber.

Other podiatrist in Grandville

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →